Dr. Schuster joined T1D Exchange as chief executive officer in 2018. She is an endocrinologist by training with over three decades of experience in the treatment, care, and research of type 1 diabetes.
Dr. Schuster comes to T1D Exchange from Eli Lilly and Company, where she launched the company’s diabetes real-world evidence partnership development program. She has held several leadership roles with Lilly, most recently as Senior Medical Director of Diabetes Medical Affairs for the United States and Puerto Rico.
Prior to joining Lilly, Dr. Schuster was a practicing physician and Professor of Adult & Pediatric Endocrinology for The Ohio State University Health System. Named to America’s Top Pediatricians, America’s Best Doctors, and Best Practices in Diabetes Management, Dr. Schuster held multiple clinical director roles at Ohio State while treating patients, teaching medical students, and advancing important diabetes research, including retrospective, real-world data analysis.